FDA
Chlorothiazide-Reserpine
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- CHLOROTHIAZIDE 250MG; RESERPINE 0.125MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CHLOROTHIAZIDE 500MG; RESERPINE 0.125MG · TabletANDA087745-001 · Discontinued
- CHLOROTHIAZIDE 250MG; RESERPINE 0.125MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA087744.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Chlorothiazide-Reserpine
- Active substance
- chlorothiazide
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Pharmobedient
- Status
- Discontinued
- FDA approval
- 6 May 1982
- Application
- ANDA087744-001